Oxygenta Pharmaceutical Ltd — Insider Trading, 29-12-2025: Insider Trading / SAST

Oxygenta Pharmaceutical Limited has announced the closure of its trading window for company securities. This restriction applies to designated persons, their immediate relatives, and connected parties, preventing them from trading in the company's shares. The trading window will remain closed until 48 hours after the financial results for the quarter are officially declared. The company plans to schedule a board meeting specifically to consider and approve these upcoming financial results. This action is a standard practice, ensuring compliance with the company’s insider trading code and promoting fair market conduct ahead of earnings announcements.